PMID- 17105404 OWN - NLM STAT- MEDLINE DCOM- 20070124 LR - 20171116 IS - 1547-3287 (Print) IS - 1547-3287 (Linking) VI - 15 IP - 5 DP - 2006 Oct TI - Syngenic bone marrow cells restore hepatic function in carbon tetrachloride-induced mouse liver injury. PG - 687-95 AB - Progenitor cells in bone marrow have been explored for the treatment of liver injury. Stem cell homing to the injured tissue is regulated through stromal cell derived factor-1 (SDF-1) and its receptor CXCR4. We hypothesized that syngenic bone marrow cells (BMCs) would restore hepatic function in the injured liver through the regulation by SDF-1/CXCR4 system. After injecting carbon tetrachloride (CCl(4)), the mice were injected with syngenic BMCs or normal saline. Morphological and functional analysis of the liver was performed. Flow cytometry for the stem cell markers and CXCR4 was done with the liver, BM, and spleen cells from each group. Carboxyfluorescein diacetate succinimidyl ester was used to trace the homing of transplanted BMCs. The SDF-1 expression of the liver was assessed by immunohistochemistry. Hepatosplenomegaly and necrosis of the CCl(4)-injected mouse liver were improved after BMCs transplantation The hepatic enzymes were increased after injury and then decreased after BMCs transplantation. The expression of stem cell markers and CXCR4 was exclusively increased in the damaged liver compared to the BM and spleen, and even more elevated after BMCs transplantation. SDF-1 expression in the liver was observed after CCl(4) injection and it was elevated after BMCs transplantation. The intrinsic and extrinsic BMCs migrate specifically to the injured liver rather than BM or spleen, and the transplanted BMCs contribute to the repair of the damaged liver. SDF-1/CXCR-4 interaction plays a role in stem cell homing toward the damaged organ, and transplanted BMCs are involved in the up-regulated SDF-1 expression seen in the injured liver. FAU - Jung, Yun-Jae AU - Jung YJ AD - Department of Microbiology, Ewha Woman's University College of Medicine, Ewha Medical Research Center, Seoul, Korea. FAU - Ryu, Kyung-Ha AU - Ryu KH FAU - Cho, Su Jin AU - Cho SJ FAU - Woo, So-Youn AU - Woo SY FAU - Seoh, Ju-Young AU - Seoh JY FAU - Chun, Chung Hyun AU - Chun CH FAU - Yoo, Kwon AU - Yoo K FAU - Moon, Il-Hwan AU - Moon IH FAU - Han, Ho-Seong AU - Han HS LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Stem Cells Dev JT - Stem cells and development JID - 101197107 RN - 0 (5-(6)-carboxyfluorescein diacetate succinimidyl ester) RN - 0 (Actins) RN - 0 (Antigens, CD34) RN - 0 (Chemokine CXCL12) RN - 0 (Chemokines, CXC) RN - 0 (Cxcl12 protein, mouse) RN - 0 (Fluoresceins) RN - 0 (Receptors, Chemokine) RN - 0 (Succinimides) RN - CL2T97X0V0 (Carbon Tetrachloride) RN - EC 3.1.3.48 (Leukocyte Common Antigens) SB - IM MH - Actins/metabolism MH - Animals MH - Antigens, CD34/immunology MH - Bone Marrow Cells/*cytology MH - *Bone Marrow Transplantation MH - Carbon Tetrachloride/*toxicity MH - *Chemical and Drug Induced Liver Injury MH - Chemokine CXCL12 MH - Chemokines, CXC/metabolism MH - Female MH - Fluoresceins/metabolism MH - Hematopoietic Stem Cells/cytology MH - Hepatomegaly/pathology MH - Injections, Intraperitoneal MH - Leukocyte Common Antigens/immunology MH - Liver/*drug effects/enzymology/*physiology MH - Liver Diseases/*physiopathology MH - Mice MH - Mice, Inbred C57BL MH - Myocytes, Smooth Muscle/cytology MH - Receptors, Chemokine/metabolism MH - Splenomegaly/pathology MH - Succinimides/metabolism MH - Up-Regulation EDAT- 2006/11/16 09:00 MHDA- 2007/01/25 09:00 CRDT- 2006/11/16 09:00 PHST- 2006/11/16 09:00 [pubmed] PHST- 2007/01/25 09:00 [medline] PHST- 2006/11/16 09:00 [entrez] AID - 10.1089/scd.2006.15.687 [doi] PST - ppublish SO - Stem Cells Dev. 2006 Oct;15(5):687-95. doi: 10.1089/scd.2006.15.687.